Alyeska Investment Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-775,299
| Closed | -$21.4M | – | 444 |
|
|
2018
Q1 | $21.4M | Sell |
775,299
-544,646
| -41% | -$15M | 0.18% | 138 |
|
|
2017
Q4 | $23.9M | Buy |
1,319,945
+565,288
| +75% | +$10.2M | 0.19% | 133 |
|
|
2017
Q3 | $12.2M | Buy |
754,657
+65,260
| +9% | +$1.05M | 0.09% | 214 |
|
|
2017
Q2 | $9.55M | Sell |
689,397
-106,934
| -13% | -$1.48M | 0.08% | 233 |
|
|
2017
Q1 | $11.9M | Buy |
796,331
+272,734
| +52% | +$4.09M | 0.1% | 239 |
|
|
2016
Q4 | $6.86M | Buy |
523,597
+327,255
| +167% | +$4.29M | 0.06% | 296 |
|
|
2016
Q3 | $3.38M | Buy |
+196,342
| New | +$3.38M | 0.03% | 342 |
|
|
2015
Q2 | – | Sell |
-156,268
| Closed | -$2.27M | – | 499 |
|
|
2015
Q1 | $2.27M | Sell |
156,268
-15,286
| -9% | -$222K | 0.03% | 333 |
|
|
2014
Q4 | $1.73M | Buy |
171,554
+45,885
| +37% | +$462K | 0.03% | 337 |
|
|
2014
Q3 | $1.05M | Buy |
+125,669
| New | +$1.05M | 0.02% | 306 |
|
|
2014
Q1 | – | Sell |
-50,000
| Closed | -$445K | – | 304 |
|
|
2013
Q4 | $445K | Buy |
+50,000
| New | +$445K | 0.02% | 242 |
|